Inventor · disambiguated record
Franco Lori
Also filed as: LORI FRANCO · LORI FRANCO C
13 granted patents·10 pending applications·213 citations·filing 1993–2017
92Inventor score
Top patents by PatentIndex Score
23 records- 0188US6420176B1Composition for delivering DNA into antigen presenting cellsGENETIC IMMUNITY LLC·Filed 1998·Granted Jul 16, 2002·86 cites·14 claims
- 0285US6194390B1Procedure to block the replication of reverse transcriptase dependent viruses by the use of inhibitors of deoxynucleotides synthesisUS HEALTH·Filed 2000·Granted Feb 27, 2001·12 cites·8 claims
- 0378US5420030AMolecular clones of HIV-1 viral strains MN-ST1 and BA-L and uses thereofUS HEALTH·Filed 1993·Granted May 30, 1995·30 cites·10 claims
- 0476US6046175AProcedure to block the replication of reverse transcriptase dependent viruses by the use of inhibitors of deoxynucleotides synthesisUS HEALTH·Filed 1994·Granted Apr 4, 2000·32 cites·22 claims
- 0572US7196186B2DNA composition and uses thereofRES INST FOR GENETIC AND HUMAN·Filed 2004·Granted Mar 27, 2007·3 cites·2 claims
- 0664US9617225B24,6-disubstituted aminopyrimidine derivatives have anti-HIV activityLORI FRANCO·Filed 2013·Granted Apr 11, 2017·2 cites·19 claims
- 0764US5576000AMolecular clones of HIV-1 viral strains MH-ST1 and BA-L, and uses thereofUS HEALTH·Filed 1995·Granted Nov 19, 1996·17 cites·5 claims
- 0864US2008234215A1DNA composition and uses thereofLISZIEWICZ JULIANNA·Filed 2007·Application pending·0 cites
- 0961US2006154892A1Procedure to block the replication of reverse transcriptase dependent viruses by the use of inhibitors of deoxynucleotides synthesisLORI FRANCO·Filed 2006·Application pending·0 cites
- 1060US2006052317A1Procedure to block the replication of reverse transcriptase dependent viruses by the use of inhibitors of deoxynucleotides synthesisLORI FRANCO·Filed 2005·Application pending·0 cites
- 1155US7910562B2Method of delivering genes into antigen presenting cells of the skinGENETIC IMMUNITY LLC·Filed 2002·Granted Mar 22, 2011·0 cites·7 claims
- 1254US5977086AMethod of inhibiting human immunodeficiency virus by combined use of hydroxyurea, a nucleoside analog, and a protease inhibitorR I G H T·Filed 1998·Granted Nov 2, 1999·16 cites·7 claims
- 1354US2009317466A1Fixed dose pharmaceutical composition comprising hyroxyurea and didanosineLORI FRANCO·Filed 2008·Application pending·0 cites
- 1450US5869313AMolecular clones of HIV-1 viral strains MN-ST1 and BA-L, and uses thereofUS HEALTH·Filed 1996·Granted Feb 9, 1999·7 cites·14 claims
- 1550US2001008905A1Procedure to block the replication of reverse transcriptase dependent viruses by the use of inhibitors of deoxynucleotides synthesisFiled 2001·Application pending·0 cites
- 1646US2002022034A1Therapeutic DNA vaccinationFiled 2001·Application pending·0 cites
- 1745US2003095988A1Method of inducing autovaccination against HIV infection using structured treatment interruptionsFiled 2000·Application pending·0 cites
- 1841US2009263828A1Novel assay for precursor T-cells having high proliferative capacity (PHPC-asay)LORI FRANCO·Filed 2009·Application pending·0 cites
- 1941US2012202223A1Ki-67 ASSAY FOR PATIENT IMMUNE SYSTEM STATUSBAEV DENIS V·Filed 2011·Application pending·0 cites
- 2039US6251874B1Method of inhibiting human immunodeficiency virus using hydroxurea and a reverse transcriptase inhibitor in vivoRES INST FOR GENETIC AND HUMAN·Filed 1998·Granted Jun 26, 2001·6 cites·2 claims
- 2137US10294218B24,6-disubstituted aminopyrimidine derivatives have anti-HIV activityVIROSTATICS SRL·Filed 2017·Granted May 21, 2019·0 cites·20 claims
- 2233US6114312AMethod of inhibiting human immunodeficiency virus by combined use of hydroxyurea, a nucleoside analog, and a protease inhibitorRES INST FOR GENETIC AND HUMAN·Filed 1997·Granted Sep 5, 2000·2 cites·9 claims
- 2329US2012022048A1Anti-proliferative substituted pyrazolo[3,4-d]pyrimidines derivatives (SPP) to inhibit immune activation, virus replication and tumor growthLORI FRANCO·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Franco Lori files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →